Interleukin-12 gene polymorphism and cervical cancer risk

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 32, Issue 5, 2009, Pages 524-528

  Kordi Tamandani, Dor Mohammad ^a,b   Shekari, Mohammad ^a,c   Suri, V ^d  

^a PANJAB UNIVERSITY   (India)

^b UNIVERSITY OF SISTAN AND BALUCHESTAN   (Iran)

^c HORMOZGAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Cervical cancer; IL 12 gene; Polymorphism

Indexed keywords

INTERLEUKIN 12P40; ORAL CONTRACEPTIVE AGENT;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE INTERACTION; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PASSIVE SMOKING; RISK ASSESSMENT; UTERINE CERVIX CANCER;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-12 SUBUNIT P40; MATERNAL AGE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK; UTERINE CERVICAL NEOPLASMS;

EID: 70350676176     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e318192519a     Document Type: Article

References (37)

1. Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2000;55:244-265.
2. Jemal A, Murray T, Samuels A, et al. Cancer statistics. CA Cancer J Clin. 2003;53:5-26.
3. Shanta V, Krishnamurthi S, Gajalakshmi CK, et al. Epidemiology of cancer of the cervix: global and national perspective. J Indian Med Assoc. 2000;98:49-52.
4. Mustea A, Sehouli J, Könsgen D, et al. Interleukin1 receptor antagonist (IL-1RA) polymorphism in women with cervical cancer. Anticancer Res. 2003;2:1099-1102. (Pubitemid 36752683)
5. Miteva L, Stanilova S. Genotype and allelic frequencies of a Taq1 polymorphism in the 3′-UTR of the IL-12 gene in Bulgarians. Trakia J Sci. 2004;2: 31-35.
6. Watford WT, Moriguchi M, Morinobu A, et al. The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev. 2003;14:361-368.
7. Gately MK, Renzetti LM, Magram J, et al. The interleukin-12/interleukin- 12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol. 1998;16:495-521.
8. Sieburth D, Jabs EW, Warrington JA, et al. Assignment of NKSF/IL 12, a unique cytokine composed of two unrelated subunits, to chromosomes 3 and 5. Genomics. 1992;14:59-62.
9. Huang D, Cancilla MR, Morahan G. Complete primary structure, chromosomal localization, and definition of polymorphisms of the gene encoding the human interleukin-12 p40 subunit. Genes Immun. 2000;1:515-520.
10. Yilmaz V, Yentur SP, Saruhan-Direskeneli G. IL-12 and IL-10 polymorphisms and their effects on cytokine production. Cytokine. 2005;30:188-194.
11. Calvo J, Martínez N, Etxagibel A, et al. Allelic frequencies of polymorphic variants of cytokine genes (IL1A, IL1B, IL1RN, IL6, IL10, IL12p40, and IFNG) in a Spanish population. Immunologia. 2002;21:76-86.
12. Zijlmans HJ, Fleuren GJ, Baelde HJ, et al. Role of tumor-derived proinflammatory cytokines GM-CSF, TNF-alpha, and IL-12 in the migration and differentiation of antigen-presenting cells in cervical carcinoma. Cancer. 2007;109:556-565.
13. Chen L, Chen D, Block E, et al. Eradication of murine bladder carcinoma by intratumor injection of a bicistronic adenoviral vector carrying cDNAs for the IL-12 heterodimer and its inhibition by the IL-12 p40 subunit homodimer. J Immunol. 1997;159:351-359.
14. Atkins MB, Robertson MJ, Gordon MH, et al. Phase I evaluation of intravenous recombinant human interleukin-12 in patients with advanced malignancies. Clin Cancer Res. 1997;3:409-417.
15. Brunda MJ, Luistro L, Hendrzak JA, et al. Role of interferon-gamma in mediating the antitumor efficacy of interleukin-12. J Immunother Emphasis Tumor Immunol. 1995;17:71-77.
16. Passmore JA, Morroni C, Shapiro S, et al. Papanicolaou smears and cervical inflammatory cytokine responses. J Inflamm (Lond). 2007;4:8.
17. Roe BA, Crabtree JS, Khan AS. Methods for DNA isolation. Part III. In: Protocols for recombinant DNA isolation, cloning, and sequencing [Internet edition]. Norman, OK: University of Oklahoma; 1995. (Available at):http://www.genome.ou.edu/protocol-book/protocol-index.html;. Also available in paper copy as: DNA isolation and sequencing. New York: Wiley; 1996.
18. Hollegaard MV, Bidwell JL. Cytokine gene polymorphism in human disease: on-line databases, Supplement 3. Genes Immun. 2006;7:269-276.
19. Mytilineos J, Laux G, Opelz G. Relevance of IL 10, TGF beta 1, TNF alpha, and IL 4R alpha gene polymorphisms in kidney transplantation: a collaborative transplant study report. Am J Transplant 2004;4:1684-1690.
20. Smith JS, Green J, Berrington de Gonzalez A, et al. Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet. 2003;361:1159-1167.
21. Kaur G, Rapthap CC, Kumar N, et al. Frequency distribution of cytokine gene polymorphisms in the healthy North Indian population. Tissue Antigensv. 2007;69:113-120.
22. Trinchieri G, Gerosa F. Immunoregulation by interleukin-12. J Leuk Biol. 1996;59:505-511.
23. Segal BM, Klinman DM, Shevach EM. Microbial products induce autoimmune disease by an IL-12 dependent pathway. J Immunol. 1997;158:5087-5090.
24. Latsi P, Pantelidis P, Vassilakis D, et al. Analysis of IL-12 p40 subunit gene and IFN-gamma G5644A polymorphisms in idiopathic pulmonary fibrosis. Respir Res. 2003;4:1-5.
25. Seegers D, Zwiers A, Strober W, et al. Taq I polymorphism in the 3′-UTR of the IL-12 p40 gene correlates with increased IL-12 secretion. Genes Immun. 2002;3:419-423.
26. Altare F, Lammas D, Revy P, et al. Inherited interleukin-12 deficiency in a child with bacille Calmette-Guérin and Salmonella enteritidis disseminated infection. J Clin Invest. 1998;102:2035-2040.
27. Morita Y, Yamamura M, Nishida K, et al. Expression of interleukin-12 in synovial tissue from patients with rheumatoid arthritis. Arthritis Rheum. 1998;41:306-314.
28. Adorini L. Interleukin 12 and autoimmune diabetes. Nat Genet. 2001;27: 218-221.
29. Windhagen A, Newcombe J, Dangond F, et al. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J Exp Med. 1995;182:1985-1996.
30. Monteleone G, Biancone L, Marasco R, et al. Interleukin-12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology. 1997;112:1169-1178.
31. Ikeda Y, Yoshida W, Noguchi T, et al. Lack of association between IL-12β gene polymorphism and autoimmune thyroid disease in Japanese patients. Endocr J. 2004;51:609-613.
32. Gollob JA, Schnipper CP, Orsini E, et al. Characterization of a novel subset of CD8(+) T cells that expands in patients receiving interleukin-12. J Clin Invest. 1998;102:561-575.
33. Hall MA, McGlinn E, Coakley G, et al. Genetic polymorphism of IL-12 p40 gene in immune-mediated disease. Genes Immun. 2000;1:219-224.
34. Wadler S, Levy D, Frederickson HL, et al. for the Eastern Cooperative Oncology Group study E1E96. A phase II trial of interleukin-12 in patients with advanced cervical cancer: clinical and immunologic correlates. Gynecol Oncol. 2004;92:957-964.
35. Dohnal A, Witt V, Hügel H, et al. Phase I study of tumor Ag-loaded IL-12 secreting semi-mature DC for the treatment of pediatric cancer. Cytotherapy. 2007;1-16.
36. Navaglia F, Basso D, Zambon CF, et al. Interleukin 12 gene polymorphisms enhance gastric cancer risk in H. pylori-infected individuals. J Med Genet. 2005;42:503-510.
37. Lau AS, Sigaroudinia M, Yeung MC, et al. Interleukin-12 induces interferongamma expression and NK cytotoxicity in cord blood mononuclear cells. Pediatr Res. 1996;39:150-155.